Thorac Cardiovasc Surg 2008; 56(7): 428-430
DOI: 10.1055/s-2008-1038351
Short Communications

© Georg Thieme Verlag KG Stuttgart · New York

Beating Heart Valve Surgery Using Stentless Xenografts as a Surgical Alternative for Patients with End-Stage Renal Failure

M. Horst1 , J. Easo1 , P. P. Hölzl1 , O. E. Dapunt1
  • 1Department of Cardiothoracic Surgery, Klinikum Oldenburg, Oldenburg, Germany
Weitere Informationen

Publikationsverlauf

Received October 17, 2007

Publikationsdatum:
22. September 2008 (online)

Preview

Introduction

Patients suffering from end-stage renal disease are an inhomogeneous high-risk group with substantial perioperative mortality and morbidity when undergoing cardiac surgical procedures [1], [2], [3]. Myocardial ischemia, reperfusion injury and myocardial edema are a few of the deleterious consequences of the traditional use of cardioplegic arrest when performing valve surgery, irrespective of type of cardioplegia used [4], [5], [6], [7]. Novel operative techniques are required to reduce these induced perioperative risks. Clinical studies in the past have demonstrated the efficacy of beating heart valve surgery in the high-risk patient using retrograde, antegrade or combined coronary perfusion with warm oxygenated blood [8], [9]. We chose to combine the superior hemodynamic profile of stentless xenografts and the concept of performing valve replacement on the empty beating heart with a continuous antegrade application of oxygenated blood in two chronic hemodialysis patients.

References

Dr. Jerry Easo

Klinikum Oldenburg
Department of Cardiothoracic Surgery

Dr. Eden Str. 10

26133 Oldenburg

Germany

Telefon: + 49 44 14 03 28 20

Fax: + 49 44 14 03 28 30

eMail: jerryeaso@hotmail.com